دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Subscription Information
doi : 10.1016/S0085-2538(23)00092-3
Volume 103, Issue 4, April 2023, Page A5
Table of Contents
doi : 10.1016/S0085-2538(23)00093-5
Volume 103, Issue 4, April 2023, Pages A7, A9, A11
Subscription Information
doi : 10.1016/S0085-2538(23)00092-3
Volume 103, Issue 4, April 2023, Page A5
Table of Contents
doi : 10.1016/S0085-2538(23)00093-5
Volume 103, Issue 4, April 2023, Pages A7, A9, A11
Advances in biodesign: artificial water channels outperforming aquaporins
Ines P.D. Costa 1 , Iain A. Drummond 2 and Olivier Devuyst
doi : 10.1016/j.kint.2023.01.015
Volume 103, Issue 4, April 2023, Pages 651-653
Novel mechanism of increased preeclampsia risk after kidney donation
Elizabeth Ann L. Enninga 1 and Vesna D. Garovic
doi : 10.1016/j.kint.2023.01.013
Volume 103, Issue 4, April 2023, Pages 653-655
Advances in biodesign: artificial water channels outperforming aquaporins
Ines P.D. Costa 1 , Iain A. Drummond 2 and Olivier Devuyst
doi : 10.1016/j.kint.2023.01.015
Volume 103, Issue 4, April 2023, Pages 651-653
Fosl1: friend or foe?
Shruti Bhargava 1 and Joachim Jankowski
doi : 10.1016/j.kint.2022.12.019
Volume 103, Issue 4, April 2023, Pages 656-658
Novel mechanism of increased preeclampsia risk after kidney donation
Elizabeth Ann L. Enninga 1 and Vesna D. Garovic
doi : 10.1016/j.kint.2023.01.013
Volume 103, Issue 4, April 2023, Pages 653-655
A transitional B-cell cytokine biomarker for risk stratifying renal transplant patients with borderline rejection
Sumoyee Basu 1 , Anthony Dorling 1 and Anita S. Chong
doi : 10.1016/j.kint.2022.12.020
Volume 103, Issue 4, April 2023, Pages 658-660
Fosl1: friend or foe?
Shruti Bhargava 1 and Joachim Jankowski
doi : 10.1016/j.kint.2022.12.019
Volume 103, Issue 4, April 2023, Pages 656-658
Kidney-specific metabolomic profiling in machine perfusate
Eugene P. Rhee
doi : 10.1016/j.kint.2022.12.025
Volume 103, Issue 4, April 2023, Pages 661-663
A transitional B-cell cytokine biomarker for risk stratifying renal transplant patients with borderline rejection
Sumoyee Basu 1 , Anthony Dorling 1 and Anita S. Chong
doi : 10.1016/j.kint.2022.12.020
Volume 103, Issue 4, April 2023, Pages 658-660
Solving the insoluble: calciprotein particles mediate bulk mineral transport
Willi Jahnen-Dechent1 and Andreas Pasch
doi : 10.1016/j.kint.2023.01.011
Volume 103, Issue 4, April 2023, Pages 663-665
Kidney-specific metabolomic profiling in machine perfusate
Eugene P. Rhee
doi : 10.1016/j.kint.2022.12.025
Volume 103, Issue 4, April 2023, Pages 661-663
Glucocorticoids for IgA nephropathy—pro
Yue-Miao Zhang 1,2,3,4,5 , Ji-Cheng Lv1,2,3,4,5 , Muh Geot Wong6 , Hong Zhang 1,2,3,4,5 and Vlado Perkovic
doi : 10.1016/j.kint.2023.01.018
Volume 103, Issue 4, April 2023, Pages 666-669
Solving the insoluble: calciprotein particles mediate bulk mineral transport
Willi Jahnen-Dechent1 and Andreas Pasch
doi : 10.1016/j.kint.2023.01.011
Volume 103, Issue 4, April 2023, Pages 663-665
First do no harm: systemic glucocorticoids should not be used for the treatment of progressive IgA nephropathy
Chee Kay Cheung 1,2 and Jonathan Barratt
doi : 10.1016/j.kint.2022.05.034
Volume 103, Issue 4, April 2023, Pages 669-673
Glucocorticoids for IgA nephropathy—pro
Yue-Miao Zhang 1,2,3,4,5 , Ji-Cheng Lv1,2,3,4,5 , Muh Geot Wong6 , Hong Zhang 1,2,3,4,5 and Vlado Perkovic
doi : 10.1016/j.kint.2023.01.018
Volume 103, Issue 4, April 2023, Pages 666-669
IgA nephropathy and glucocorticoids—a limbo dance?
Brad H. Rovin
doi : 10.1016/j.kint.2023.01.017
Volume 103, Issue 4, April 2023, Page 673
First do no harm: systemic glucocorticoids should not be used for the treatment of progressive IgA nephropathy
Chee Kay Cheung 1,2 and Jonathan Barratt
doi : 10.1016/j.kint.2022.05.034
Volume 103, Issue 4, April 2023, Pages 669-673
P32: a sex- and gender-sensitive model for evidence-based precision medicine: from knowledge generation to implementation in the field of kidney transplantation
Ruth Sapir-Pichhadze 1,2,3 and Sabine Oertelt-Prigione
doi : 10.1016/j.kint.2022.12.026
Volume 103, Issue 4, April 2023, Pages 674-685
IgA nephropathy and glucocorticoids—a limbo dance?
Brad H. Rovin
doi : 10.1016/j.kint.2023.01.017
Volume 103, Issue 4, April 2023, Page 673
The transcription factor Fosl1 preserves Klotho expression and protects from acute kidney injury
Leticia Cuarental 1,2 , Marta Ribagorda 1,2 , Maria I. Ceballos 1,2 , Aranzazu Pintor-Chocano 1,2 , Sol M. Carriazo 1,2 , Ana Dopazo 3 , Enrique Vazquez 3 , Beatriz Suarez-Alvarez 6 , Pablo Cannata-Ortiz 7 , Ana B. Sanz 1,2 , Alberto Ortiz 1,2,4,8 and Maria D. Sanchez-Nin ̃ o
doi : 10.1016/j.kint.2022.11.023
Volume 103, Issue 4, April 2023, Pages 686-701
P32: a sex- and gender-sensitive model for evidence-based precision medicine: from knowledge generation to implementation in the field of kidney transplantation
Ruth Sapir-Pichhadze 1,2,3 and Sabine Oertelt-Prigione
doi : 10.1016/j.kint.2022.12.026
Volume 103, Issue 4, April 2023, Pages 674-685
Osteopontin mediation of disturbed flow–induced endothelial mesenchymal transition through CD44 is a novel mechanism of neointimal hyperplasia in arteriovenous fistulae for hemodialysis access
Chi-Jen Chang 1 , Ying-Ju Lai 2 , Ying-Chang Tung 1 , Lung-Sheng Wu 1 , Lung-An Hsu 1 , Chi-Nan Tseng 3 , Gwo-Jyh Chang 4 , Kai-Chien Yang 5,6,7 and Yung-Hsin Yeh 1
doi : 10.1016/j.kint.2022.12.022
Volume 103, Issue 4, April 2023, Pages 702-718
The transcription factor Fosl1 preserves Klotho expression and protects from acute kidney injury
Leticia Cuarental 1,2 , Marta Ribagorda 1,2 , Maria I. Ceballos 1,2 , Aranzazu Pintor-Chocano 1,2 , Sol M. Carriazo 1,2 , Ana Dopazo 3 , Enrique Vazquez 3 , Beatriz Suarez-Alvarez 6 , Pablo Cannata-Ortiz 7 , Ana B. Sanz 1,2 , Alberto Ortiz 1,2,4,8 and Maria D. Sanchez-Nin ̃ o
doi : 10.1016/j.kint.2022.11.023
Volume 103, Issue 4, April 2023, Pages 686-701
Downregulation of G protein–coupled receptor kinase 4 protects against kidney ischemia-reperfusion injury
Donghai Yang1,2,8 , Ming Tang 1,2,8 , Mingming Zhang 1,2,8 , Hongmei Ren 1,2 , Xiaoping Li 1,2 , Ziyue Zhang 1,2 , Bo He 1,2 , Song Peng 3 , Wei Wang 1,2 , Dandong Fang 1,2 , Yi Song 4 , Yao Xiong 5 , Zhi Zhao Liu 5 , Lijia Liang 5 , Weibin Shi1,2 , Chunjiang Fu 1,2 , Yijie Hu4 , Pedro A. Jose6 , Lin Zhou 1,2 , Yu Han 1,2 and Chunyu Zeng
doi : 10.1016/j.kint.2022.12.023
Volume 103, Issue 4, April 2023, Pages 719-734
Osteopontin mediation of disturbed flow–induced endothelial mesenchymal transition through CD44 is a novel mechanism of neointimal hyperplasia in arteriovenous fistulae for hemodialysis access
Chi-Jen Chang 1 , Ying-Ju Lai 2 , Ying-Chang Tung 1 , Lung-Sheng Wu 1 , Lung-An Hsu 1 , Chi-Nan Tseng 3 , Gwo-Jyh Chang 4 , Kai-Chien Yang 5,6,7 and Yung-Hsin Yeh 1
doi : 10.1016/j.kint.2022.12.022
Volume 103, Issue 4, April 2023, Pages 702-718
Reduction of anaerobic glycolysis contributes to angiotensin II-induced podocyte injury with foot process effacement
Zhaowei Chen 1,2,3 , Zijing Zhu 1,2,3 , Wei Liang 1,2,3 , Zilv Luo 1,2 , Jijia Hu 1,2 , Jun Feng 1,2 , Zongwei Zhang 1,2 , Qiang Luo 1,2 , Hongxia Yang 1,2 and Guohua Ding
doi : 10.1016/j.kint.2023.01.007
Volume 103, Issue 4, April 2023, Pages 735-748
Downregulation of G protein–coupled receptor kinase 4 protects against kidney ischemia-reperfusion injury
Donghai Yang1,2,8 , Ming Tang 1,2,8 , Mingming Zhang 1,2,8 , Hongmei Ren 1,2 , Xiaoping Li 1,2 , Ziyue Zhang 1,2 , Bo He 1,2 , Song Peng 3 , Wei Wang 1,2 , Dandong Fang 1,2 , Yi Song 4 , Yao Xiong 5 , Zhi Zhao Liu 5 , Lijia Liang 5 , Weibin Shi1,2 , Chunjiang Fu 1,2 , Yijie Hu4 , Pedro A. Jose6 , Lin Zhou 1,2 , Yu Han 1,2 and Chunyu Zeng
doi : 10.1016/j.kint.2022.12.023
Volume 103, Issue 4, April 2023, Pages 719-734
Transitional B cell cytokines risk stratify early borderline rejection after renal transplantation
Aravind Cherukuri 1,2 , Khodor I. Abou-Daya 1 , Raad Chowdhury 2 , Rajil B. Mehta 1,2 , Sundaram Hariharan 1,2 , Parmjeet Randhawa 1,3 and David M. Rothstein
doi : 10.1016/j.kint.2022.10.026
Volume 103, Issue 4, April 2023, Pages 749-761
Reduction of anaerobic glycolysis contributes to angiotensin II-induced podocyte injury with foot process effacement
Zhaowei Chen 1,2,3 , Zijing Zhu 1,2,3 , Wei Liang 1,2,3 , Zilv Luo 1,2 , Jijia Hu 1,2 , Jun Feng 1,2 , Zongwei Zhang 1,2 , Qiang Luo 1,2 , Hongxia Yang 1,2 and Guohua Ding
doi : 10.1016/j.kint.2023.01.007
Volume 103, Issue 4, April 2023, Pages 735-748
Untargeted metabolomics of perfusate and their association with hypothermic machine perfusion and allograft failure
Richard X. Liu 1 , Neel Koyawala 1 , Heather R. Thiessen-Philbrook 1 , Mona D. Doshi 2 , Peter P. Reese 3 , Isaac E. Hall 4 , Sumit Mohan 5,6 and Chirag R. Parikh
doi : 10.1016/j.kint.2022.11.020
Volume 103, Issue 4, April 2023, Pages 762-771
Transitional B cell cytokines risk stratify early borderline rejection after renal transplantation
Aravind Cherukuri 1,2 , Khodor I. Abou-Daya 1 , Raad Chowdhury 2 , Rajil B. Mehta 1,2 , Sundaram Hariharan 1,2 , Parmjeet Randhawa 1,3 and David M. Rothstein
doi : 10.1016/j.kint.2022.10.026
Volume 103, Issue 4, April 2023, Pages 749-761
Post hoc analysis of SUSTAIN 6 and PIONEER 6 trials suggests that people with type 2 diabetes at high cardiovascular risk treated with semaglutide experience more stable kidney function compared with placebo
Katherine R. Tuttle 1 , Heidrun Bosch-Traberg2 , David Z.I. Cherney 3 , Samy Hadjadj 4 , Jack Lawson 5 , Ofri Mosenzon 6 , Søren Rasmussen 7 and Stephen C. Bain
doi : 10.1016/j.kint.2022.12.028
Volume 103, Issue 4, April 2023, Pages 772-781
Untargeted metabolomics of perfusate and their association with hypothermic machine perfusion and allograft failure
Richard X. Liu 1 , Neel Koyawala 1 , Heather R. Thiessen-Philbrook 1 , Mona D. Doshi 2 , Peter P. Reese 3 , Isaac E. Hall 4 , Sumit Mohan 5,6 and Chirag R. Parikh
doi : 10.1016/j.kint.2022.11.020
Volume 103, Issue 4, April 2023, Pages 762-771
Cord blood effectively resists mineralization through mechanisms that stabilize calciprotein particles
Edward R. Smith 1,2 , Paul J. Champion de Crespigny 1,2,3 , Fatima Vally 3 , Tim D. Hewitson 1,2 , Nigel D. Toussaint 1,2 , Thomas J. Cade 3 and Stephen G. Holt
doi : 10.1016/j.kint.2022.11.019
Volume 103, Issue 4, April 2023, Pages 782-786
Post hoc analysis of SUSTAIN 6 and PIONEER 6 trials suggests that people with type 2 diabetes at high cardiovascular risk treated with semaglutide experience more stable kidney function compared with placebo
Katherine R. Tuttle 1 , Heidrun Bosch-Traberg2 , David Z.I. Cherney 3 , Samy Hadjadj 4 , Jack Lawson 5 , Ofri Mosenzon 6 , Søren Rasmussen 7 and Stephen C. Bain
doi : 10.1016/j.kint.2022.12.028
Volume 103, Issue 4, April 2023, Pages 772-781
Interference of urinary albumin-to-creatinine ratio measurement by glycosuria: clinical implications when using SGLT-2 inhibitors
Daniel Chapman 1,3 , Parminder K. Judge 1,3 , Rebecca J. Sardell 1,3 , Natalie Staplin 1,2 , Thomas Arnold 1 , Doreen Zhu 1 , Sarah Ng1 , Stewart Moffat 1 , Martin J. Landray 1,2 , Colin Baigent 1,2 , Michael Hill 1,2 , Richard Haynes 1,2 , Sarah Clark 1 and William G. Herrington
doi : 10.1016/j.kint.2022.12.027
Volume 103, Issue 4, April 2023, Pages 787-790
Cord blood effectively resists mineralization through mechanisms that stabilize calciprotein particles
Edward R. Smith 1,2 , Paul J. Champion de Crespigny 1,2,3 , Fatima Vally 3 , Tim D. Hewitson 1,2 , Nigel D. Toussaint 1,2 , Thomas J. Cade 3 and Stephen G. Holt
doi : 10.1016/j.kint.2022.11.019
Volume 103, Issue 4, April 2023, Pages 782-786
Impact of study design on vaccine effectiveness estimates of 2 mRNA COVID-19 vaccine doses in patients with stage 5 chronic kidney disease
Kyla L. Naylor 1,2,3 , Eric McArthur 1,3 , Stephanie N. Dixon 1,2,3 , Jeffrey C. Kwong 1,4,5,6,7 , Doneal Thomas 8 , Shabnam Balamchi 9 , Peter G. Blake 3,8,10 , Amit X. Garg 1,2,3,10 , Mohammad Atiquzzaman 11 , Michelle A. Hladunewich 8,12 , Adeera Levin 11,13,14 , Angie Yeung 8 and Matthew J. Oliver
doi : 10.1016/j.kint.2023.01.009
Volume 103, Issue 4, April 2023, Pages 791-797
Interference of urinary albumin-to-creatinine ratio measurement by glycosuria: clinical implications when using SGLT-2 inhibitors
Daniel Chapman 1,3 , Parminder K. Judge 1,3 , Rebecca J. Sardell 1,3 , Natalie Staplin 1,2 , Thomas Arnold 1 , Doreen Zhu 1 , Sarah Ng1 , Stewart Moffat 1 , Martin J. Landray 1,2 , Colin Baigent 1,2 , Michael Hill 1,2 , Richard Haynes 1,2 , Sarah Clark 1 and William G. Herrington
doi : 10.1016/j.kint.2022.12.027
Volume 103, Issue 4, April 2023, Pages 787-790
Corrigendum to “Myeloid cyclooxygenase-2/prostaglandin E2/E-type prostanoid receptor 4 promotes transcription factor MafB-dependent inflammatory resolution in acute kidney injury.� Kidney Int. 2022;101:79–91
Yu Pan1,2,3,5 , Shirong Cao1,2,5 , Andrew S. Terker1,2 , Jiaqi Tang1,2 , Kensuke Sasaki1,2 , Yinqiu Wang1,2 , Aolei Niu1,2 , Wentian Luo1,2 , Dhouha Daassi1,2 , Xiaofeng Fan1,2 , Suwan Wang1,2 , Matthew H. Wilson1,2 , Ming-Zhi Zhang1,2 and Raymond C. Harris
doi : 10.1016/j.kint.2023.01.014
Volume 103, Issue 4, April 2023, Page 798
Impact of study design on vaccine effectiveness estimates of 2 mRNA COVID-19 vaccine doses in patients with stage 5 chronic kidney disease
Kyla L. Naylor 1,2,3 , Eric McArthur 1,3 , Stephanie N. Dixon 1,2,3 , Jeffrey C. Kwong 1,4,5,6,7 , Doneal Thomas 8 , Shabnam Balamchi 9 , Peter G. Blake 3,8,10 , Amit X. Garg 1,2,3,10 , Mohammad Atiquzzaman 11 , Michelle A. Hladunewich 8,12 , Adeera Levin 11,13,14 , Angie Yeung 8 and Matthew J. Oliver
doi : 10.1016/j.kint.2023.01.009
Volume 103, Issue 4, April 2023, Pages 791-797
Spheroplasts in the urinary sediment
Giovanni Battista Fogazzi 1 and Giuseppe Garigali
doi : 10.1016/j.kint.2022.12.009
Volume 103, Issue 4, April 2023, Page 799
Corrigendum to “Myeloid cyclooxygenase-2/prostaglandin E2/E-type prostanoid receptor 4 promotes transcription factor MafB-dependent inflammatory resolution in acute kidney injury.� Kidney Int. 2022;101:79–91
Yu Pan1,2,3,5 , Shirong Cao1,2,5 , Andrew S. Terker1,2 , Jiaqi Tang1,2 , Kensuke Sasaki1,2 , Yinqiu Wang1,2 , Aolei Niu1,2 , Wentian Luo1,2 , Dhouha Daassi1,2 , Xiaofeng Fan1,2 , Suwan Wang1,2 , Matthew H. Wilson1,2 , Ming-Zhi Zhang1,2 and Raymond C. Harris
doi : 10.1016/j.kint.2023.01.014
Volume 103, Issue 4, April 2023, Page 798
Pulmonary-renal syndrome in IgA vasculitis
Sascha T. Bender 1 , Peter R. Mertens 1 and Christian Gross 1
doi : 10.1016/j.kint.2022.12.010
Volume 103, Issue 4, April 2023, Page 800
Spheroplasts in the urinary sediment
Giovanni Battista Fogazzi 1 and Giuseppe Garigali
doi : 10.1016/j.kint.2022.12.009
Volume 103, Issue 4, April 2023, Page 799
The Case | Hematuria and hypercalcemia in a kidney transplant recipient
Athiphat Banjongjit 1 , Thunyatorn Wuttiputhanun 1 , Jakapat Vanichanan 2 , Thornthun Ueaphongsukkit2 , Kroonpong Iampenkhae 3 , Yingyos Avihingsanon 1,4,5 and Natavudh Townamchai
doi : 10.1016/j.kint.2022.10.010
Volume 103, Issue 4, April 2023, Pages 801-802
Pulmonary-renal syndrome in IgA vasculitis
Sascha T. Bender 1 , Peter R. Mertens 1 and Christian Gross 1
doi : 10.1016/j.kint.2022.12.010
Volume 103, Issue 4, April 2023, Page 800
Acknowledgment of reviewers
doi : 10.1016/j.kint.2023.02.003
Volume 103, Issue 4, April 2023, Pages 803-809
The Case | Hematuria and hypercalcemia in a kidney transplant recipient
Athiphat Banjongjit 1 , Thunyatorn Wuttiputhanun 1 , Jakapat Vanichanan 2 , Thornthun Ueaphongsukkit2 , Kroonpong Iampenkhae 3 , Yingyos Avihingsanon 1,4,5 and Natavudh Townamchai
doi : 10.1016/j.kint.2022.10.010
Volume 103, Issue 4, April 2023, Pages 801-802
Acknowledgment of reviewers
doi : 10.1016/j.kint.2023.02.003
Volume 103, Issue 4, April 2023, Pages 803-809
